Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-11-06 Sale | 2024-11-07 4:38 pm | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 5,000 | $91.28 | $456,400 | 73,127 (Direct) | View |
| 2024-11-06 Sale | 2024-11-07 4:32 pm | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 25,590 | $91.5 | $2,341,485 | 221,269 (Direct) | View |
| 2024-10-01 Sale | 2024-10-02 4:58 pm | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 2,000 | $83.83 | $167,660 | 100,189 (Direct) | View |
| 2024-09-12 Sale | 2024-09-13 7:07 pm | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 21,246 | $84.5 | $1,795,287 | 248,859 (Direct) | View |
| 2024-09-12 Sale | 2024-09-13 5:08 pm | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 29,357 | $83.78 | $2,459,577 | 78,127 (Direct) | View |
| 2024-08-28 Sale | 2024-08-29 3:23 pm | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 9,513 | $78.03 | $742,299 | 105,466 (Direct) | View |
| 2024-08-13 Sale | 2024-08-14 2:23 pm | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 5,490 | $73.98 | $406,150 | 114,979 (Direct) | View |
| 2024-07-01 Sale | 2024-07-01 8:06 pm | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 2,000 | $68.63 | $137,260 | 96,380 (Direct) | View |
| 2024-06-17 Purchase | 2024-06-20 8:31 pm | ASSEMBLY BIOSCIENCES INC. | ASMB | GILEAD SCIENCES INC. 10% Owner | 179,500 | $0 | $0 | 1,448,472 (Direct) | View |
| 2024-04-02 Purchase | 2024-04-03 6:50 pm | Xilio Therapeutics Inc. | XLO | GILEAD SCIENCES INC. 10% Owner | 485,250 | $0.76 | $368,790 | 11,227,923 (Direct) | View |
| 2024-04-01 Sale | 2024-04-02 6:38 pm | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 2,000 | $72.96 | $145,920 | 96,304 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-11-06 Exercise | 2024-11-07 4:32 pm | N/A 2032-03-10 | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 25,000 | $0 | 221,269 (Direct) | View |
| 2024-11-06 Exercise | 2024-11-07 4:32 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 25,000 | $57.92 | 221,269 (Direct) | View |
| 2024-10-25 Exercise | 2024-10-28 3:09 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 514 | $0 | 50,012 (Direct) | View |
| 2024-10-25 Tax Withholding | 2024-10-28 3:09 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 242 | $89 | 50,012 (Direct) | View |
| 2024-09-12 Exercise | 2024-09-13 7:07 pm | N/A 2032-03-10 | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 25,000 | $0 | 248,859 (Direct) | View |
| 2024-09-12 Exercise | 2024-09-13 7:07 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 25,000 | $57.92 | 248,859 (Direct) | View |
| 2024-09-10 Exercise | 2024-09-11 7:41 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 639 | $0 | 50,254 (Direct) | View |
| 2024-09-10 Tax Withholding | 2024-09-11 7:41 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 307 | $81.44 | 50,254 (Direct) | View |
| 2024-09-10 Exercise | 2024-09-11 7:38 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership | 901 | $0 | 49,768 (Direct) | View |
| 2024-09-10 Tax Withholding | 2024-09-11 7:38 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership | 292 | $81.44 | 49,768 (Direct) | View |
| 2024-09-10 Exercise | 2024-09-11 7:33 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 3,821 | $0 | 139,008 (Direct) | View |
| 2024-09-10 Tax Withholding | 2024-09-11 7:33 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 1,766 | $81.44 | 139,008 (Direct) | View |
| 2024-09-10 Exercise | 2024-09-11 7:30 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 10,295 | $0 | 611,267 (Direct) | View |
| 2024-09-10 Tax Withholding | 2024-09-11 7:30 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 4,749 | $81.44 | 611,267 (Direct) | View |
| 2024-09-10 Exercise | 2024-09-11 7:23 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 3,752 | $0 | 147,429 (Direct) | View |
| 2024-09-10 Tax Withholding | 2024-09-11 7:23 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 1,734 | $81.44 | 147,429 (Direct) | View |
| 2024-09-10 Exercise | 2024-09-11 7:20 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 3,641 | $0 | 178,046 (Direct) | View |
| 2024-09-10 Tax Withholding | 2024-09-11 7:20 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 1,682 | $81.44 | 178,046 (Direct) | View |
| 2024-08-10 Exercise | 2024-08-12 4:22 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership | 3,678 | $0 | 50,060 (Direct) | View |
| 2024-08-10 Tax Withholding | 2024-08-12 4:22 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership | 980 | $73.66 | 50,060 (Direct) | View |
| 2024-07-25 Exercise | 2024-07-26 5:28 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 8,744 | $0 | 88,977 (Direct) | View |
| 2024-07-25 Tax Withholding | 2024-07-26 5:28 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 2,917 | $76.51 | 88,977 (Direct) | View |
| 2024-06-10 Exercise | 2024-06-11 7:25 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 3,639 | $0 | 179,728 (Direct) | View |
| 2024-06-10 Tax Withholding | 2024-06-11 7:25 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer | 1,662 | $65.25 | 179,728 (Direct) | View |
| 2024-06-10 Exercise | 2024-06-11 7:23 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership | 901 | $0 | 51,040 (Direct) | View |
| 2024-06-10 Tax Withholding | 2024-06-11 7:23 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership | 255 | $65.25 | 51,040 (Direct) | View |
| 2024-06-10 Exercise | 2024-06-11 7:20 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 10,295 | $0 | 616,016 (Direct) | View |
| 2024-06-10 Tax Withholding | 2024-06-11 7:20 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO | 4,693 | $65.25 | 616,016 (Direct) | View |
| 2024-06-10 Exercise | 2024-06-11 7:18 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 3,751 | $0 | 164,166 (Direct) | View |
| 2024-06-10 Tax Withholding | 2024-06-11 7:18 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer | 1,714 | $65.25 | 164,166 (Direct) | View |
| 2024-06-10 Exercise | 2024-06-11 7:15 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 3,820 | $0 | 142,774 (Direct) | View |
| 2024-06-10 Tax Withholding | 2024-06-11 7:15 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer | 1,744 | $65.25 | 142,774 (Direct) | View |
| 2024-06-10 Exercise | 2024-06-11 7:12 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 638 | $0 | 53,478 (Direct) | View |
| 2024-06-10 Tax Withholding | 2024-06-11 7:12 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 204 | $65.25 | 53,478 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-09 5:57 pm | N/A 2034-05-08 | GILEAD SCIENCES INC. | GILD | BARTON JACQUELINE K Director | 14,958 | $0 | 37,188 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-09 5:30 pm | N/A 2034-05-08 | GILEAD SCIENCES INC. | GILD | LOVE TED W Director | 14,958 | $0 | 15,470 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-09 5:26 pm | N/A 2034-05-08 | GILEAD SCIENCES INC. | GILD | Rodriguez Javier Director | 14,958 | $0 | 23,350 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-09 5:23 pm | N/A 2034-05-08 | GILEAD SCIENCES INC. | GILD | WELTERS ANTHONY Director | 14,958 | $0 | 22,880 (Direct) | View |
| 2024-05-08 Tax Withholding | 2024-05-09 5:16 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | MANWANI HARISH Director | 451 | $64.92 | 25,521 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-09 5:16 pm | N/A 2034-05-08 | GILEAD SCIENCES INC. | GILD | MANWANI HARISH Director | 14,958 | $0 | 25,521 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-09 5:08 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Bluestone Jeffrey Director | 14,958 | $0 | 16,845 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-09 3:46 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Horning Sandra Director | 14,958 | $0 | 20,449 (Direct) | View |
| 2024-05-08 Option Award | 2024-05-09 3:38 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Kramer Kelly A. Director | 14,958 | $0 | 30,242 (Direct) | View |
| 2024-04-25 Tax Withholding | 2024-04-26 4:30 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 158 | $65.27 | 53,682 (Direct) | View |
| 2024-04-25 Exercise | 2024-04-26 4:30 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 515 | $0 | 53,682 (Direct) | View |
Ownership | 2024-04-19 4:31 pm | N/A N/A | LEAP THERAPEUTICS INC. | LPTX | GILEAD SCIENCES INC. 10% Owner | 0 | $0 | 5,319,148 (Direct) | View |
Ownership | 2024-04-03 6:48 pm | N/A N/A | Xilio Therapeutics Inc. | XLO | GILEAD SCIENCES INC. 10% Owner | 0 | $0 | 6,860,223 (Direct) | View |
| 2024-03-28 Option Award | 2024-03-29 5:19 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Lofton Kevin E Director | 34 | $0 | 3,258 (Direct) | View |
| 2024-03-10 Tax Withholding | 2024-03-12 4:19 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 846 | $75.12 | 138,088 (Direct) | View |
| 2024-03-10 Exercise | 2024-03-12 4:19 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 2,555 | $0 | 138,088 (Direct) | View |
| 2024-03-10 Option Award | 2024-03-12 4:19 pm | N/A 2034-03-10 | GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC | 65,795 | $0 | 138,088 (Direct) | View |
| 2024-03-10 Tax Withholding | 2024-03-12 3:57 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership | 790 | $75.12 | 94,565 (Direct) | View |
| 2024-03-10 Exercise | 2024-03-12 3:57 pm | N/A N/A | GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership | 2,682 | $0 | 94,565 (Direct) | View |
| 2024-03-10 Option Award | 2024-03-12 3:57 pm | N/A 2034-03-10 | GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership | 18,485 | $0 | 94,565 (Direct) | View |